Risk Factors Update Summary

• Net income decreased significantly from $444,050 in 2022 to $210,679 in 2023.
• Expect decrease in demand, Kaiser revenue down to 17% from 18%, totaling $1,304 million debt.
• Decline in demand for travel nurse business, stable in Q3-Q4, below pre-pandemic levels.
• Addition of provisions for the recovery of Erroneously Awarded Compensation from Executive Officers post-Accounting Restatement.
• Regulation increase affecting healthcare staffing, tech-enabled services, and automation impact highlighted.
• Net cash provided by operating activities decreased from $372 million in 2022 to $653 million in 2023.
• Revenue for Nurse and Allied Solutions decreased from $3,982,453 in 2022 to $2,624,509 in 2023.
• Acquired MSI Systems Corp., DrWanted.com LLC, and Connetics to digitize processes and retain talent.
• Total debt outstanding increased from $850,000 to $1,310,000, a significant rise of $460,000.
• Other liabilities decreased from $249.3 million to $116.3 million primarily due to lower cash paid for income taxes.
• Segment operating income for Nurse and Allied Solutions decreased from $576,226 in 2022 to $362,158 in 2023.
• Long-term portion of notes payable rose from $843,505 to $1,304,688, an increase of $461,183.
• Inclusion of a clause specifying the calculation of Erroneously Awarded Compensation based on stock price or total shareholder return.
• Nurse and allied solutions revenue down to 69% from 76%, physician solutions up to 18%.
• Repurchased 6 million shares at $85.04 per share, totaling $1,123 million, excluding excise taxes.
• Outstanding letters of credit decreased from $378 to $269, showing a reduction of $109.
• Revenue decreased to $3,789 million in 2023 from $5,243 million in 2022.
• Introduction of conditions where recovery of Erroneously Awarded Compensation may be deemed impracticable.
• Income taxes receivable decreased from $15 million to $7 million due to an overpayment of estimated taxes.
• The company repurchased 2,282 more shares of common stock in 2023 compared to 2022.
• The company increased its share repurchase authorization from $850,000 to $1,350,000.
• The company entered into an accelerated share repurchase agreement, prepaying $200,000 for shares.